aTyr Pharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $120.7M
Liabilities Breakdown FY2023
Total Liabilities: $30.0M
Asset Breakdown
Total Assets: $120.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $22.5M | 18.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.5M | 4.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $92.6M | 76.7% |
Liabilities Breakdown
Total Liabilities: $30.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.5M | 11.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $26.5M | 88.2% |